Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
03/17/1999 | EP0902087A2 Histidine kinase |
03/17/1999 | EP0902086A1 Tuberculosis vaccine |
03/17/1999 | EP0902085A1 Recombinant human erythropoietin with advantageous glycosylation profile |
03/17/1999 | EP0902035A2 Altered thermostable DNA polymerases for sequencing |
03/17/1999 | EP0901531A1 Process for direct sequencing during template amplification |
03/17/1999 | EP0901530A1 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof |
03/17/1999 | EP0901529A2 Teichoic acid enzymes and assays |
03/17/1999 | EP0901528A1 Integration cassette for improvement of transgenesis in eukaryotes |
03/17/1999 | EP0901527A2 Regulating metabolism by modifying the level of trehalose-6-phosphate |
03/17/1999 | EP0901526A1 Cortistatin: neuropeptides, compositions and methods |
03/17/1999 | EP0901525A2 Peptide antagonists derived from the transmembrane domains of g protein-coupled receptors |
03/17/1999 | EP0901524A1 Intracellular antifreeze polypeptides and nucleic acids |
03/17/1999 | EP0901523A1 Immortalized avian cell lines |
03/17/1999 | EP0901522A1 Immortal avian cells |
03/17/1999 | EP0901503A1 Synthetic glucagon binding proteins |
03/17/1999 | EP0901501A1 Nucleoside derivatives with photo-unstable protective groups |
03/17/1999 | EP0901463A1 Glycerolipidic compounds used for the transfer of an active substance into a target cell |
03/17/1999 | EP0692026B1 A human t-cell receptor of the g-protein coupled receptor family |
03/17/1999 | EP0648222A4 Methods of single nucleotide primer extension to detect specific alleles and kits therefor. |
03/17/1999 | EP0614465B1 HYBRID PROTEIN BETWEEN CS FROM PLASMODIUM AND HBsAG |
03/17/1999 | EP0563296B1 Optimization of binding proteins |
03/17/1999 | EP0560885B1 Recombinant cells that highly express chromosomally-integrated heterologous genes |
03/17/1999 | EP0558631B1 Recombinant avirulent salmonella antifertility vaccines |
03/17/1999 | EP0485611B1 Method of preparing plasmid having capabilities of expressing and processing after translation of retrovirus gene, plasmid obtained thereby and product of expression thereof |
03/17/1999 | CN1211282A Seed shattering |
03/17/1999 | CN1211281A Bacterial donor cell useful in conjugation |
03/17/1999 | CN1211280A Thrombin muteins as antidotes for thrombin inhibitors |
03/17/1999 | CN1211279A Composition and methods for the treatment and diagnosis of breast cancer |
03/17/1999 | CN1211255A Ob receptor and method of diagnosing and treating weight |
03/17/1999 | CN1210889A Method for preparing monomer insulin |
03/17/1999 | CN1042553C New composition for nucleic acid purification |
03/17/1999 | CA2244330A1 Novel histidine kinase |
03/16/1999 | US5883244 Lytic β-1,3-glucanase gene |
03/16/1999 | US5883241 Antisense and antibodies |
03/16/1999 | US5883240 Genetic sequences encoding glucocorticoid dehydrogenases and uses therefor |
03/16/1999 | US5883239 aroA |
03/16/1999 | US5883238 Process for typing HLA-B using specific primers and probes sets |
03/16/1999 | US5883230 Multidomain hematopoiesis stimulators |
03/16/1999 | US5883227 Multiple sclerosis associated polypeptide |
03/16/1999 | US5883226 Nucleotide sequences of genes |
03/16/1999 | US5883225 Polypeptides and sequence |
03/16/1999 | US5883224 Characterization of transfer factors and methods of use |
03/16/1999 | US5883082 Compositions and methods for preventing and treating allograft rejection |
03/16/1999 | US5883076 Inducing plant defense mechanisms; wound healing agents; genetic engineering; gene expression |
03/16/1999 | US5883071 Mammalian growth factor |
03/16/1999 | US5882927 Oligonucleotide inhibition of protein kinase C |
03/16/1999 | US5882925 Cdna contained in plasmids, amino acid sequences and cultures |
03/16/1999 | US5882924 Dna encodes fusion proteins |
03/16/1999 | US5882914 Nucleic acids encoding the hypoxia inducible factor-1 |
03/16/1999 | US5882912 Retrovirus isolated from humans |
03/16/1999 | US5882911 Enzyme with rhamnogalacturonase activity |
03/16/1999 | US5882910 Lipid kinase |
03/16/1999 | US5882909 Gene codes for sulfolobus with phenylalanine, methionine, valine, tyrosine, arginine and aspartic acid |
03/16/1999 | US5882908 Isolated human inducible nitric oxide synthase |
03/16/1999 | US5882907 Design of new ribozymes capable of self-catalyzed trans-splicing which are based upon the catalytic core of a group i intron are described |
03/16/1999 | US5882898 Cells and vectors with polynucleotides |
03/16/1999 | US5882897 yitJ |
03/16/1999 | US5882896 M protein |
03/16/1999 | US5882894 Nucleic acids encoding CR8 polypeptides, vector and transformed cell thereof, and expression thereof |
03/16/1999 | US5882893 Modulation of acetylcholine responses in cells; antisense molecules; expression vectors; genetic engineering; nervous system, cardiovascular, glandular, eating, psychological, and smooth muscle disorders |
03/16/1999 | US5882892 Polypeptides and dna(rna) encoding and screening for bactericides |
03/16/1999 | US5882891 Polynucleotide segments |
03/16/1999 | US5882890 Nucleic acid and amino acid sequences of novel regulators of g-protein signaling and to the use of these sequences in the diagnosis, prevention, and treatment of disorders associated with cell proliferation and inflammation |
03/16/1999 | US5882889 Response regulator in a two component signal transduction system |
03/16/1999 | US5882888 DNA integration by transposition |
03/16/1999 | US5882887 Proteins for genetic engineering |
03/16/1999 | US5882885 Polypeptides and polynucleotides |
03/16/1999 | US5882883 Process for the production of secondary metabolites |
03/16/1999 | US5882879 Method for influencing β-lactam antibiotic production and for isolation of large quantities of ACV synthetase |
03/16/1999 | US5882877 Cystic fibrosis treatment; genetic engineering |
03/16/1999 | US5882876 Amino acid sequences in proteins and markers of cancer cells |
03/16/1999 | US5882875 Methods for identifying multidrug resistant tumor cells |
03/16/1999 | US5882873 Human DNA sequence encoding a kidney ATP-dependent potassium channel |
03/16/1999 | US5882871 Saliva binding protein |
03/16/1999 | US5882869 Plant adenylosuccinate synthetase and DNA coding therefor |
03/16/1999 | US5882867 Detection of nucleic acids by formation of template-dependent product |
03/16/1999 | US5882864 Biomarkers and targets for diagnosis, prognosis and management of prostate disease |
03/16/1999 | US5882860 Hybridization of nucleic acid derived from cell with polynucleotide; genetic engineering; suppressing gene expression |
03/16/1999 | US5882858 Cloning and uses of the genetic locus BCL-6 |
03/16/1999 | US5882857 Forming multiple copies of a target sequence of a target polynucleotide |
03/16/1999 | US5882856 Primers that allow multiplex pcr reactions to be designed and carried out without elaborate optimization steps, irrespective of the potentially divergent properties of the different primers used. |
03/16/1999 | US5882855 DNA encoding a human dopamine D1 receptor and uses thereof |
03/16/1999 | US5882852 Hepatitic C virus (HCV) core gene nucleotide sequences and related methods of detecting major and minor genotypes of HCV isolates |
03/16/1999 | US5882851 Dna molecule coding for a cytochrome p-450 monooxygenase that catalyzes the conversion of an amino acid to the corresponding n-hydroxyamino acid and the conversion of said n-hydroxyamino acid to the corresponding oxime |
03/16/1999 | US5882668 Maize protein for insect control |
03/16/1999 | US5882655 Serpulina hyodysenteriae vaccine comprising a hygene mutant |
03/16/1999 | US5882653 Vibrio cholerae 01 (CVD111) and non-01 (CVD112 and CVD112RM) serogroup vaccine strains, methods of making same and products thereof |
03/16/1999 | US5882643 Identification and characterization of such factors which can play a role in preventing, ameliorating or correcting infections, dysfunctions or diseases. a novel lep gene of streptococcus pneumoniae. |
03/16/1999 | US5882642 Genetically engineered transmissible hypovirulence |
03/16/1999 | CA2244232A1 Novel def |
03/16/1999 | CA2236363A1 Novel compound |
03/16/1999 | CA2066882C Strains of bread-making yeast, a process for obtaining the same, and the corresponding fresh and dry new yeasts |
03/16/1999 | CA2008825C Reg protein |
03/16/1999 | CA2008695C Gene switch |
03/16/1999 | CA1340449C Expression of dna sequences derived from nocardioform microorganisms |
03/16/1999 | CA1340448C Selectable herpes virus saimiri vectors for human cells |
03/16/1999 | CA1340431C Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor |
03/15/1999 | CA2246274A1 Automated incubator and reader for nucleic acid assays |
03/11/1999 | WO1999012038A1 Detection of measles virus-specific antibodies |
03/11/1999 | WO1999012036A1 Reversible immobilization of arginine-tagged moieties on a silicate surface |